Management Strategies and Prognosis of Pulmonary Embolism-3 Trial - MAPPET-3

Description:

MAPPET-3 was a randomized, placebo-controlled trial to compare the effects of treatment with heparin plus alteplase vs. heparin alone on the outcome of hemodynamically stable patients with acute submassive pulmonary embolism (PE) and pulmonary hypertension and/or right ventricular dysfunction.